Literature DB >> 23062652

Prolonged preoperative hospitalization correlates with worse outcomes after colectomy for acute fulminant ulcerative colitis.

Brian A Coakley1, Dana Telem, Scott Nguyen, Kai Dallas, Celia M Divino.   

Abstract

BACKGROUND: Although total abdominal colectomy has long been considered definitive treatment for fulminant ulcerative colitis refractory to medical management, the optimal timing of surgery remains controversial. Early surgical intervention may be beneficial to patients with acute ulcerative colitis. Our goal was to compare outcomes after colectomy for fulminant ulcerative colitis and to identify preoperative factors that are predictive of poor outcome.
METHODS: The charts of 107 patients treated by total abdominal colectomy with ileostomy for fulminant ulcerative colitis between 2004 and 2009 were retrospectively reviewed. Twenty-nine patients sustained a major postoperative complication; 78 patients recovered uneventfully. Perioperative statistics, 30-day readmission/reoperation rates, and perioperative morbidity and mortality were compared using the Student t and Fisher exact tests and χ(2) analysis where appropriate.
RESULTS: White blood cell count at admission was significantly higher among patients who developed postoperative complications, but there were no differences in patient characteristics, other acute illness measures, or disease extent. Univariate analysis revealed that patients who developed postoperative complications underwent colectomy significantly later (3.6 vs 7.4 days; P = .01) than those who recovered uneventfully. Laparoscopic colectomy took significantly longer than open surgery, but did not affect postoperative morbidity. Multivariate analysis revealed duration of preoperative medical treatment to be the only significant predictor of increased risk of postoperative morbidity. Follow-up data revealed that similar percentages of patients in both groups eventually underwent ileal pouch anal anastomosis (IPAA; 68% vs 77%; P = .5).
CONCLUSION: Prolonged duration of preoperative medical treatment correlates with poor postoperative outcomes after total abdominal colectomy for fulminant ulcerative colitis. In addition, sustaining postoperative complications did not prevent patients from eventually undergoing IPAA.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23062652     DOI: 10.1016/j.surg.2012.08.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective study.

Authors:  Toshimitsu Araki; Yoshiki Okita; Motoi Uchino; Hiroki Ikeuchi; Iwao Sasaki; Yuji Funayama; Kouhei Fukushima; Kitarou Futami; Kiyoshi Maeda; Tsuneo Iiai; Michio Itabashi; Kazuo Hase; Satoshi Motoya; Atsuo Kitano; Tsunekazu Mizushima; Kotaro Maeda; Minako Kobayashi; Yasuhiko Mohri; Masato Kusunoki
Journal:  Surg Today       Date:  2013-12-12       Impact factor: 2.549

Review 2.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

3.  Early colectomy in steroid-refractory acute severe ulcerative colitis improves operative outcome.

Authors:  Sujeet Kumar Saha; Rajesh Panwar; Ameet Kumar; Sujoy Pal; Vineet Ahuja; Nihar Ranjan Dash; Govind Makharia; Peush Sahni
Journal:  Int J Colorectal Dis       Date:  2017-09-17       Impact factor: 2.571

4.  Outcomes for Ulcerative Colitis With Delayed Emergency Colectomy Are Worse When Controlling for Preoperative Risk Factors.

Authors:  Ira L Leeds; Margaret H Sundel; Alodia Gabre-Kidan; Bashar Safar; Brindusa Truta; Jonathan E Efron; Sandy H Fang
Journal:  Dis Colon Rectum       Date:  2019-05       Impact factor: 4.585

Review 5.  The Management of the Hospitalized Ulcerative Colitis Patient: the Medical-Surgical Conundrum.

Authors:  Michele Carvello; Joseph Watfah; Marcin Włodarczyk; Antonino Spinelli
Journal:  Curr Gastroenterol Rep       Date:  2020-02-10

6.  Delay in emergency hernia surgery is associated with worse outcomes.

Authors:  Ira L Leeds; Christian Jones; Sandra R DiBrito; Joseph V Sakran; Elliott R Haut; Alistair J Kent
Journal:  Surg Endosc       Date:  2019-11-18       Impact factor: 4.584

7.  Impact of transjugular intrahepatic portosystemic shunt on post-colectomy complications in patients with ulcerative colitis and primary sclerosing cholangitis.

Authors:  Gursimran Kochhar; Udayakumar Navaneethan; Jose Mari Parungao; Jason Hartman; Ranjan Gupta; Rocio Lopez; Arthur J McCullough; Baljiendra Kapoor; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-12-16

Review 8.  Current approaches to the management of new-onset ulcerative colitis.

Authors:  Renée Marchioni Beery; Sunanda Kane
Journal:  Clin Exp Gastroenterol       Date:  2014-05-09

9.  Hepatocyte growth factor, hepatocyte growth factor activator and arginine in a rat fulminant colitis model.

Authors:  Nathan P Zwintscher; Puja M Shah; Shashikumar K Salgar; Christopher R Newton; Justin A Maykel; Ahmed Samy; Murad Jabir; Scott R Steele
Journal:  Ann Med Surg (Lond)       Date:  2016-04-05

10.  Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome.

Authors:  Natsuki Ishida; Takahiro Miyazu; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.